What is Antihypertensive Drugs Market?
Antihypertensive drugs are a class of drugs that are used to treat hypertension which prevents complications of high blood pressure, such as stroke and myocardial infarction. These drugs are frequently used by patients and may influence the conduct of anesthesia. The most important and widely used medications are thiazide diuretics, calcium channel blockers, ACE inhibitors, angiotensin II receptor antagonists (ARBs), and beta-blockers.
The market study is being classified and major geographies with country level break-up.
Novartis International AG (Switzerland), Pfizer Inc. (United States), Johnson & Johnson (United States), Sanofi S.A (France), Lupin Limited (India), Ranbaxy Laboratories (India), Merck & Co. (United States), AstraZeneca plc (United Kingdom), Daiichi Sankyo Company (Japan) and Takeda Pharmaceutical Company (Japan) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Actelion (Switzerland) and United Therapeutics Corporation (United States).
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Antihypertensive Drugs market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Antihypertensive Drugs market by Type, Application and Region.
On the basis of geography, the market of Antihypertensive Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increased Prevalence of Hypertension Worldwide
- Rise in the Number of Hypertension Cases Spreading Awareness
- Increased Number of Online Pharmacies
- Increased Research and Development Activities
- High Demand for Effective Treatments for Hypertension
- Side Effects of the Antihypertensive Drugs
- Low Awareness in Developing Countries
- Increasing Preference for Combination Therapy
- Growth in the Healthcare Industry Worldwide
- Robust Increase in the Distribution Channels
- Stringent Government Rules and Regulations for Drug Approvals
Market Leaders and some development strategies
In August 2020, Johnson & Johnson has announced that it has entered into a definitive agreement to acquire Momenta Pharmaceuticals, Inc. (Momenta), a company that discovers and develops novel therapies for immune-mediated diseases, in an all-cash transaction.
Key Target AudienceAntihypertensive Drugs Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase